Eprozinol
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Transdermal Device Containing
- TABLE VI.- Classification Obtained by Linear Discriminant Analysis on Carcinogenic Activity Study : (Compounds Cataloged on Merck Index)
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pharmaabkommen A1 E
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Customs Tariff - Schedule Xxi - 1
- Solutions Your Api Intermediates
- Australian Statistics on Medicines 2009
- Medications, Dry Mouth and Dental Caries Among Older People: a Longitudinal Study
- Literature Search Strategy for Treatment of Stable
- (12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
- (12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
- Pharmaceutical Appendix to the Tariff Schedule 2
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- (12) Patent Application Publication (10) Pub. No.: US 2008/0220441 A1 Birnbaum Et Al
- Ligand P-Gp Inhibition
- (19) United States (12) Patent Application Publication (10) Pub
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr